China National Accord Medicines Corporation Ltd.

XSEC:000028 Stock Report

Market Cap: CN¥15.3b

China National Accord Medicines Future Growth

Future criteria checks 1/6

China National Accord Medicines is forecast to grow earnings and revenue by 6.2% and 5.7% per annum respectively. EPS is expected to grow by 5.6% per annum. Return on equity is forecast to be 8.3% in 3 years.

Key information

6.2%

Earnings growth rate

5.6%

EPS growth rate

Healthcare earnings growth23.0%
Revenue growth rate5.7%
Future return on equity8.3%
Analyst coverage

Good

Last updated11 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:000028 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202685,6501,718N/A1,7006
12/31/202582,1261,615N/A1,6507
12/31/202477,5111,569N/A1,6803
9/30/202475,3581,4752,4522,753N/A
6/30/202474,8761,5122,0732,380N/A
3/31/202475,8811,6261,7692,093N/A
12/31/202375,4771,5992,6152,937N/A
9/30/202375,4121,6291,6561,968N/A
6/30/202375,7021,6432,6743,005N/A
3/31/202374,9791,5972,6722,988N/A
12/31/202273,4431,4872,2382,560N/A
9/30/202272,7651,3101,9312,293N/A
6/30/202271,3241,2691,0981,467N/A
3/31/202269,4591,2601,3601,744N/A
12/31/202168,3581,3361,2851,655N/A
9/30/202166,9791,478592939N/A
6/30/202165,6431,5009701,294N/A
3/31/202162,8751,4821,5791,884N/A
12/31/202059,6491,4021,2091,503N/A
9/30/202056,2441,3062,6632,937N/A
6/30/202054,3581,2622,0582,312N/A
3/31/202053,5391,2171,8652,113N/A
12/31/201952,7871,2681,7612,013N/A
9/30/201950,7791,2431,5461,817N/A
6/30/201947,9431,2181,9652,236N/A
3/31/201944,9371,2171,1401,399N/A
12/31/201843,1221,2111,0671,323N/A
9/30/201841,7511,1821,1101,338N/A
6/30/201841,5171,143N/A1,282N/A
3/31/201841,2981,078N/A923N/A
12/31/201741,2631,058N/A1,285N/A
9/30/201741,4181,080N/A1,155N/A
6/30/201741,2111,084N/A871N/A
3/31/201741,1591,205N/A959N/A
12/31/201641,2481,187N/A1,472N/A
9/30/201649,2491,263N/A1,878N/A
6/30/201645,5681,199N/A1,839N/A
3/31/201641,870984N/A1,286N/A
12/31/201537,819928N/A1,457N/A
9/30/201525,740721N/A201N/A
6/30/201525,155693N/A136N/A
3/31/201524,683682N/A-189N/A
12/31/201423,954652N/A-797N/A
9/30/201423,418629N/A-369N/A
6/30/201422,680607N/A-258N/A
3/31/201421,864545N/A-70N/A
12/31/201321,199520N/A465N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000028's forecast earnings growth (6.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 000028's earnings (6.2% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 000028's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000028's revenue (5.7% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 000028's revenue (5.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000028's Return on Equity is forecast to be low in 3 years time (8.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y